Back to Search

BARBARA EISENBERG, MD

MD

Obstetrics & Gynecology Physician

NPI: 1811191976IndividualAccepts Medicare

Specialties, Licenses & Credentials

Obstetrics & Gynecology PhysicianPrimary

Obstetrics & Gynecology

Code: 207V00000X

2007-01050(NC)MD463879(PA)

CMS Specialties

PrimaryOBSTETRICS/GYNECOLOGY

Education

OTHER

Class of 2003

Research & Publications (20)

Engineering channels: atomic biology.
PMID 18443300·Proc Natl Acad Sci U S A·2008
8-other
Mechanical spikes from nerve terminals.
PMID 17307819·Biophys J·2007
8-other
Combining imatinib with surgery in gastrointestinal stromal tumors: rationale and ongoing trials.
PMID 17101065·Clin Colorectal Cancer·2006
6-review
Proteins, channels and crowded ions.
PMID 12646387·Biophys Chem·2003
6-review
Pharmacotherapy of gastrointestinal stromal tumours.
PMID 12783584·Expert Opin Pharmacother·2003
6-review
Why can't protons move through water channels?
PMID 14645038·Biophys J·2003
8-other
Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors.
PMID 14682111·Oncology (Williston Park)·2003
6-review
Ions and inhibitors in the binding site of HIV protease: comparison of Monte Carlo simulations and the linearized Poisson-Boltzmann theory.
PMID 19217848·Biophys J·2009
4-observational
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cells.
PMID 19116881·Nutr Cancer·2009
8-other
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
PMID 19671739·Mol Cancer Ther·2009
3-trial
Ionic selectivity in L-type calcium channels by electrostatics and hard-core repulsion.
PMID 19398776·J Gen Physiol·2009
7-preclinical
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.
PMID 19585585·Genes Chromosomes Cancer·2009
8-other
Targeted therapies: GIST adjuvant therapy-some answers and more questions.
PMID 19644534·Nat Rev Clin Oncol·2009
8-other
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.
PMID 18942073·J Surg Oncol·2009
3-trial
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors.
PMID 18550829·Proc Natl Acad Sci U S A·2008
8-other
Volume exclusion in calcium selective channels.
PMID 18199663·Biophys J·2008
8-other
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
PMID 18235121·J Clin Oncol·2008
3-trial
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
PMID 18259941·Cancer Invest·2008
8-other
The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.
PMID 18818517·Cell Cycle·2008
6-review
A biological porin engineered into a molecular, nanofluidic diode.
PMID 17691852·Nano Lett·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4051 FREEMANSBURG AVE
EASTON, PA 18045

Location

Practice Location

4051 FREEMANSBURG AVE, EASTON, PA
(484) 503-7474

Quick Facts

NPI
1811191976
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
23
Publications
20

Are you this provider?

Claim Your Profile